Report Detail

Request for Sample of this report

Other Global Vinblastinesulphate (CAS 143-67-9) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3174145
    • |
  • 25 March, 2019
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

Scope of the Report:
Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn’t survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.
The worldwide market for Vinblastinesulphate (CAS 143-67-9) is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 21 million US$ in 2024, from 19 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Vinblastinesulphate (CAS 143-67-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other

Market Segment by Applications, can be divided into
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vinblastinesulphate (CAS 143-67-9) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vinblastinesulphate (CAS 143-67-9), with price, sales, revenue and global market share of Vinblastinesulphate (CAS 143-67-9) in 2017 and 2018.
Chapter 3, the Vinblastinesulphate (CAS 143-67-9) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vinblastinesulphate (CAS 143-67-9) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vinblastinesulphate (CAS 143-67-9) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vinblastinesulphate (CAS 143-67-9) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Vinblastinesulphate (CAS 143-67-9) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 >98% Vinblastinesulphate
      • 1.2.2 97-98% Vinblastinesulphate
      • 1.2.3 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Lymphoma
      • 1.3.2 Lung Cancer
      • 1.3.3 Breast & Ovarian Cancer
      • 1.3.4 Leukemia
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Guangzhou Hanfang Pharmaceutical
      • 2.1.1 Business Overview
      • 2.1.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Hainan Vinca Biological Medicine Technology
      • 2.2.1 Business Overview
      • 2.2.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Guangzhou Person Pharmaceutical
      • 2.3.1 Business Overview
      • 2.3.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Hainan Yueyang Biotechnology
      • 2.4.1 Business Overview
      • 2.4.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Hubei Honch Pharmaceutical
      • 2.5.1 Business Overview
      • 2.5.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Fine Chemicals Corporation
      • 2.6.1 Business Overview
      • 2.6.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Hengtengfu Biological Products
      • 2.7.1 Business Overview
      • 2.7.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Vinkem
      • 2.8.1 Business Overview
      • 2.8.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Vinblastinesulphate (CAS 143-67-9) Market Analysis by Regions

    • 4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 4.5 South America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    5 North America Vinblastinesulphate (CAS 143-67-9) by Country

    • 5.1 North America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    6 Europe Vinblastinesulphate (CAS 143-67-9) by Country

    • 6.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 6.3 UK Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 6.4 France Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) by Country

    • 7.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 7.5 India Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    8 South America Vinblastinesulphate (CAS 143-67-9) by Country

    • 8.1 South America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) by Countries

    • 9.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2014-2019)

    10 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Type

    • 10.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Type (2014-2019)
    • 10.2 >98% Vinblastinesulphate Sales Growth and Price
      • 10.2.1 Global >98% Vinblastinesulphate Sales Growth (2014-2019)
      • 10.2.2 Global >98% Vinblastinesulphate Price (2014-2019)
    • 10.3 97-98% Vinblastinesulphate Sales Growth and Price
      • 10.3.1 Global 97-98% Vinblastinesulphate Sales Growth (2014-2019)
      • 10.3.2 Global 97-98% Vinblastinesulphate Price (2014-2019)
    • 10.4 Other Sales Growth and Price
      • 10.4.1 Global Other Sales Growth (2014-2019)
      • 10.4.2 Global Other Price (2014-2019)

    11 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Application

    • 11.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2014-2019)
    • 11.2 Lymphoma Sales Growth (2014-2019)
    • 11.3 Lung Cancer Sales Growth (2014-2019)
    • 11.4 Breast & Ovarian Cancer Sales Growth (2014-2019)
    • 11.5 Leukemia Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)

    • 12.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)
      • 12.2.2 Europe Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)
      • 12.2.4 South America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Market Forecast (2019-2024)
    • 12.3 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Type (2019-2024)
    • 12.4 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Vinblastinesulphate (CAS 143-67-9) . Industry analysis & Market Report on Vinblastinesulphate (CAS 143-67-9) is a syndicated market report, published as Global Vinblastinesulphate (CAS 143-67-9) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Vinblastinesulphate (CAS 143-67-9) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,208.56
      		4,812.84
      		6,417.12
      		531,604.80
      		797,407.20
      		1,063,209.60
      		292,702.80
      		439,054.20
      		585,405.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo